| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 |
| FORM 8-K CURRENT REPORT |
| Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Date of Report (Date of earliest event reported)
August 19, 2009
GLOBAL MED TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
| Colorado | 0-22083 | 84-1116894 | ||
| (State or other jurisdiction of | (Commission File No.) | (I.R.S. Employer | ||
| incorporation) | Identification No.) | |||
| 12600 West Colfax, Suite C-420, Lakewood, Colorado | 80215 | |||
| (Address of principal executive offices) | (Zip Code) | |||
| (303) 238-2000 | ||||
| (Registrant’s telephone number, including area code) | ||||
| Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the |
| registrant under any of the following provisions: |
| ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of |
On August 19, 2009, Karen B. Davis informed Global Med Technologies, Inc. (the “Company”) that she intends to resign from her position as Chief Financial Officer of the Company effective as of September 18, 2009.
- 2 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GLOBAL MED TECHNOLOGIES, INC. | ||||
| By: /s/ Michael I. Ruxin, M.D. | ||||
| Michael I. Ruxin, M.D. | ||||
| Chairman of the Board and Chief Executive Officer | ||||
| Date: August 25, 2009 | ||||
- 3 -